Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Press Releases

New Senior Level Appointments in IAVI’s Medical Affairs Department

February 28, 2014

IAVI is very pleased to share some important news regarding the new appointments of two highly-valued, integral senior staff in our Medical Affairs Department. Pat Fast, most recently Chief Medical Officer at IAVI, has transitioned into the role ofSenior Technical Advisor in Research and Development, effective February 1, 2013.  Pat will have specific responsibilities in IAVI’s…

Read more

Press Releases

IAVI and Partners Initiate Early Clinical Study of New Strategy to Help Prevent HIV

February 28, 2014

Prototype candidate and potential new method to help prevent infection via broadly neutralizing antibodies will be assessed for safety, tolerability, durability NEW YORK – IAVI, the International AIDS Vaccine Initiative, today announced the start of a Phase I clinical trial in the U.K. examining a prototype candidate and a potential new method to prevent HIV infection.…

Read more

Press Releases

Achieving a Sustainable End to AIDS Will Require HIV Vaccine, Says Anthony S. Fauci of NIAID

February 28, 2014

Although antiretroviral treatment and current prevention options have considerably reduced HIV infections and AIDS-related deaths, a safe and effective vaccine is needed to end the global AIDS pandemic expeditiously and sustainably, according to a new commentary from Anthony S. Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the…

Read more

Press Releases

IAVI Applauds News of Promising New Approach to Vaccine Design

February 28, 2014

Proof-of-concept for vaccine candidate that can elicit broadly neutralizing antibodies could be applied to HIV, other challenging viruses NEW YORK – IAVI, the International AIDS Vaccine Initiative, congratulates researchers at The Scripps Research Institute (TSRI) for successfully employing new “designer proteins” to create a vaccine that, in preclinical studies, was shown to  elicit broadly neutralizing…

Read more

Press Releases

IAVI Mourns Passing of Dr. Reinhard Kurth, Former Scientific Advisory Committee Chair

February 28, 2014

Dr. Reinhard Kurth, a leading biomedical scientist who served as Chair of the IAVI Scientific Advisory Committee from June 2010 to June 2013 and a member of the IAVI Board of Directors, passed away on February 2, 2014.  Dr. Kurth leaves a strong legacy of public service and commitment to public health in Germany and…

Read more

Press Releases

IAVI Congratulates Deborah Birx, MD, on Her Nomination as the Next U.S. Global AIDS Coordinator

February 28, 2014

The International AIDS Vaccine Initiative (IAVI) congratulates Deborah Birx, MD, on her nomination as the next U.S. Global AIDS Coordinator.  “Dr. Birx is a longtime advocate for a robust and comprehensive global response to HIV and AIDS that includes a vaccine,” said IAVI CEO Margie McGlynn. “She is a strong champion of innovative approaches and tools…

Read more

Press Releases

Further Analysis of STEP AIDS Vaccine Trial Reaffirms Earlier Trend

February 5, 2008

February 05, 2008 Further analysis of STEP AIDS vaccine trial data points to pre-existing Ad5 immunity and lack of circumcision as factors in heightened vulnerability to HIV infection February 5, 2008 – A new analysis of the data from the late-stage AIDS vaccine trial known as the STEP study reinforces an earlier analysis from the…

Read more